Healthcare provider profile · identity verified

Edgar Rivera Martinez, M.D.

General Practice · AIBONITO, PR · NPI 1972576049

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Famotidine	Famotidine	611	85
Atorvastatin Calcium	Atorvastatin Calcium	588	141
Levothyroxine Sodium	Levothyroxine Sodium	401	58
Pantoprazole Sodium	Pantoprazole Sodium	399	61
Gabapentin	Gabapentin	395	58
Synthroid	Levothyroxine Sodium	383	46
Amlodipine Besylate	Amlodipine Besylate	321	61
Montelukast Sodium	Montelukast Sodium	315	48
Lisinopril	Lisinopril	293	65
Losartan Potassium	Losartan Potassium	291	67
Omeprazole	Omeprazole	280	41
Tamsulosin Hcl	Tamsulosin Hcl	212	35
Metformin Hcl	Metformin Hcl	208	49
Rosuvastatin Calcium	Rosuvastatin Calcium	207	58
Clopidogrel	Clopidogrel Bisulfate	199	41
Metoprolol Succinate	Metoprolol Succinate	197	41
Fluticasone Propionate	Fluticasone Propionate	189	41
Clonazepam	Clonazepam	165	37
Nabumetone	Nabumetone	151	51
Baclofen	Baclofen	148	53
Metoprolol Tartrate	Metoprolol Tartrate	144	31
Hydrochlorothiazide	Hydrochlorothiazide	142	26
Irbesartan	Irbesartan	141	33
Simvastatin	Simvastatin	137	30
Furosemide	Furosemide	134	23
Pregabalin	Pregabalin	131	25
Temazepam	Temazepam	126	21
Alendronate Sodium	Alendronate Sodium	124	23
Donepezil Hcl	Donepezil Hcl	120	17
Fenofibrate	Fenofibrate	116	22
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	112	19
Carvedilol	Carvedilol	108	21
Albuterol Sulfate Hfa	Albuterol Sulfate	105	19
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	102	31
Allopurinol	Allopurinol	94	12
Metformin Hcl Er	Metformin Hcl	83	19
Nifedipine Er	Nifedipine	81	18
Eliquis	Apixaban	80	13
Sure Comfort	Syringe And Needle,insulin,1ml	74	16
Sucralfate	Sucralfate	73	20
Trazodone Hcl	Trazodone Hcl	73	17
Levetiracetam	Levetiracetam	70	suppressed
Sertraline Hcl	Sertraline Hcl	68	14
Humulin N	Insulin Nph Human Isophane	64	suppressed
Meloxicam	Meloxicam	62	24
Farxiga	Dapagliflozin Propanediol	59	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	59	14
Sure Comfort	Syringe-Needle,insulin,0.5 Ml	58	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	55	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	52	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	50	suppressed
Prednisone	Prednisone	50	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	48	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	47	suppressed
Hydralazine Hcl	Hydralazine Hcl	46	suppressed
Lamotrigine	Lamotrigine	46	suppressed
Duloxetine Hcl	Duloxetine Hcl	44	suppressed
Warfarin Sodium	Warfarin Sodium	42	suppressed
Cilostazol	Cilostazol	40	suppressed
Alprazolam	Alprazolam	39	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	39	suppressed
Humulin R	Insulin Regular, Human	38	suppressed
Latanoprost	Latanoprost	37	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	36	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Arnuity Ellipta	Fluticasone Furoate	35	suppressed
Diclofenac Sodium	Diclofenac Sodium	35	12
Lorazepam	Lorazepam	35	suppressed
Naproxen	Naproxen	35	12
Amitriptyline Hcl	Amitriptyline Hcl	34	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	34	suppressed
Tramadol Hcl	Tramadol Hcl	34	14
Insulin Lispro	Insulin Lispro	32	suppressed
Methotrexate	Methotrexate Sodium	32	suppressed
Digoxin	Digoxin	31	suppressed
Pravastatin Sodium	Pravastatin Sodium	31	suppressed
Ramipril	Ramipril	31	suppressed
Rivastigmine	Rivastigmine Tartrate	31	suppressed
Anastrozole	Anastrozole	30	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	30	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	24
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Lansoprazole	Lansoprazole	29	suppressed
Topiramate	Topiramate	29	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	29	suppressed
Glipizide	Glipizide	28	suppressed
Sure Comfort	Syring-Needl,disp,insul,0.3 Ml	28	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Azithromycin	Azithromycin	27	22
Calcitriol	Calcitriol	27	suppressed
Ibuprofen	Ibuprofen	27	suppressed
Levo-T	Levothyroxine Sodium	27	suppressed
Methylprednisolone	Methylprednisolone	26	20
Xigduo Xr	Dapaglifloz Propaned/Metformin	26	suppressed
Ciclopirox	Ciclopirox	25	13
Ezetimibe	Ezetimibe	25	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	suppressed
Trijardy Xr	Empaglifloz/Linaglip/Metformin	25	suppressed
Carbamazepine	Carbamazepine	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Meclizine Hcl	Meclizine Hcl	23	suppressed
Methimazole	Methimazole	23	suppressed
Potassium Chloride	Potassium Chloride	23	suppressed
Raloxifene Hcl	Raloxifene Hcl	23	suppressed
Atenolol	Atenolol	22	suppressed
Gemfibrozil	Gemfibrozil	22	suppressed
Sulindac	Sulindac	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Diclofenac Potassium	Diclofenac Potassium	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Risperidone	Risperidone	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Sildenafil Citrate	Sildenafil Citrate	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Brilinta	Ticagrelor	15	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	15	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	15	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Ibandronate Sodium	Ibandronate Sodium	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Ranolazine Er	Ranolazine	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	14	11
Premarin	Estrogens, Conjugated	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	12
Azathioprine	Azathioprine	13	suppressed
Colchicine	Colchicine	13	suppressed
Primidone	Primidone	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Ursodiol	Ursodiol	13	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Etodolac	Etodolac	12	suppressed
Galantamine Hbr	Galantamine Hbr	12	suppressed
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	12	suppressed
Humalog	Insulin Lispro	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Synjardy	Empagliflozin/Metformin Hcl	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Complera	Emtricita/Rilpivirine/Tenof Df	11	suppressed
Easy Touch Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error